275 related articles for article (PubMed ID: 32726432)
21. Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.
Slavin TP; Coffee B; Bernhisel R; Logan J; Cox HC; Marcucci G; Weitzel J; Neuhausen SL; Mancini-DiNardo D
Cancer Genet; 2019 Jun; 235-236():31-38. PubMed ID: 31056428
[TBL] [Abstract][Full Text] [Related]
22. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
[TBL] [Abstract][Full Text] [Related]
23. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis.
Kim H; Saka B; Knight S; Borges M; Childs E; Klein A; Wolfgang C; Herman J; Adsay VN; Hruban RH; Goggins M
Clin Cancer Res; 2014 Apr; 20(7):1865-72. PubMed ID: 24486587
[TBL] [Abstract][Full Text] [Related]
24. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
25. Tolerability of Breast Radiotherapy Among Carriers of
Modlin LA; Flynn J; Zhang Z; Cahlon O; Mueller B; Khan AJ; Gillespie EF; McCormick B; Stadler ZK; Robson ME; Powell SN; Braunstein LZ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250389
[TBL] [Abstract][Full Text] [Related]
26. ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma.
Ahmed M; Li L; Pinnix C; Dabaja B; Nomie K; Lam L; Wang M
Crit Rev Oncol Hematol; 2016 Nov; 107():14-19. PubMed ID: 27823642
[TBL] [Abstract][Full Text] [Related]
27. Two novel variants in the ATM gene causing ataxia-telangiectasia, including a duplication of 90 kb: Utility of targeted next-generation sequencing in detection of copy number variation.
Martin-Rodriguez S; Calvo-Ferrer A; Ortega-Unanue N; Samaniego-Jimenez L; Sanz-Izquierdo MP; Bernardo-Gonzalez I
Ann Hum Genet; 2019 Jul; 83(4):266-273. PubMed ID: 30888062
[TBL] [Abstract][Full Text] [Related]
28. ATM Mutations in Cancer: Therapeutic Implications.
Choi M; Kipps T; Kurzrock R
Mol Cancer Ther; 2016 Aug; 15(8):1781-91. PubMed ID: 27413114
[TBL] [Abstract][Full Text] [Related]
29. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
Prodosmo A; Buffone A; Mattioni M; Barnabei A; Persichetti A; De Leo A; Appetecchia M; Nicolussi A; Coppa A; Sciacchitano S; Giordano C; Pinnarò P; Sanguineti G; Strigari L; Alessandrini G; Facciolo F; Cosimelli M; Grazi GL; Corrado G; Vizza E; Giannini G; Soddu S
J Exp Clin Cancer Res; 2016 Sep; 35(1):135. PubMed ID: 27599564
[TBL] [Abstract][Full Text] [Related]
30. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
31. Breast Irradiation Is Well Tolerated in Carriers of a Pathogenic ATM Variant.
Zureick AH; Zakalik D; Quinn TJ; Rangarajan TS; Grzywacz VP; Rotenbakh LR; Chen PY; Dilworth JT
Pract Radiat Oncol; 2024; 14(1):e29-e39. PubMed ID: 37742832
[TBL] [Abstract][Full Text] [Related]
32. ATM, radiation, and the risk of second primary breast cancer.
Bernstein JL; ; Concannon P
Int J Radiat Biol; 2017 Oct; 93(10):1121-1127. PubMed ID: 28627265
[TBL] [Abstract][Full Text] [Related]
33. Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.
Marshall CH; Sokolova AO; McNatty AL; Cheng HH; Eisenberger MA; Bryce AH; Schweizer MT; Antonarakis ES
Eur Urol; 2019 Oct; 76(4):452-458. PubMed ID: 30797618
[TBL] [Abstract][Full Text] [Related]
34. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
[TBL] [Abstract][Full Text] [Related]
35. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
[TBL] [Abstract][Full Text] [Related]
36. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
37. Germline mutation in the TP53 gene in uveal melanoma.
Hajkova N; Hojny J; Nemejcova K; Dundr P; Ulrych J; Jirsova K; Glezgova J; Ticha I
Sci Rep; 2018 May; 8(1):7618. PubMed ID: 29769598
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update.
Lavin MF
Radiother Oncol; 1998 May; 47(2):113-23. PubMed ID: 9683357
[TBL] [Abstract][Full Text] [Related]
39. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
[TBL] [Abstract][Full Text] [Related]
40. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
